These peptides, which include glucose-dependent insulinotropic peptide (GIP) and GLP1, are responsible for the incretin effect, which explains why the stimulus for insulin release is stronger upon receiving an oral glucose load, rather than an intravenous one.40,41 Dipeptidyl peptidase 4 (DPP-4) is the protein that cleaves and inactivates GLP-1 and GIP in a few minutes,40 thus the medications that inhibit said aminopeptidase increase the circulating levels of the incretins, enabling the stimulation of glucose-dependent insulin secretion in the pancreatic islets, through membrane receptors in the cells, to persist.41 Sitagliptin, linagliptin, saxagliptin, vildagliptin, and alogliptin, among others, belong to the group of DPP-4 inhibitors (iDDP-4)
These side effects occur because the medication slows down gastric emptying and reduces appetite, particularly during the initial or dose escalation phase
Neurol Sci 33:13931396 Stanley CA (2004) Carnitine deficiency disorders in children
Increasing water consumption and using fragrance-free moisturizers often resolves minor itching within days
For glutathione to be more effective: Include antioxidants in your diet
